Does Medicare cover Xtampza ER (oxycodone extended-release)?
Medicare coverage for Xtampza ER depends on whether the product is listed on your plan’s formulary and whether you’re using the correct benefit category (typically Part D for a prescription drug). In most cases, extended-release opioid prescriptions are covered under Medicare Part D plans when they meet plan rules and prior authorization or quantity limits, if applicable.
Because coverage is plan-specific, the most accurate way to confirm is to check your Part D plan’s formulary entry for “Xtampza ER” (brand name) and compare it with the formulary alternatives.
What Medicare part usually covers Xtampza ER?
Xtampza ER is a prescription medicine, so it is generally covered through:
- Medicare Part D (prescription drug coverage), if you have it.
- Rarely, a different Medicare context if a prescription is provided during a covered medical service (but outpatient prescription coverage is still usually Part D).
Will Xtampza ER be covered right away, or do I need prior authorization?
Many Part D plans apply rules for opioids, such as:
- Prior authorization (approval before the plan will pay)
- Quantity limits (caps on days’ supply)
- Step therapy (trying a different medication first)
Whether Xtampza ER triggers these steps depends on your exact plan and dose.
How can I check my coverage quickly?
Check these in your Medicare Part D plan materials (online or by phone):
- Formulary status: whether Xtampza ER is “covered” and at what tier
- Prior authorization requirements
- Quantity limit and days’ supply rules
- Your cost-sharing (copay or coinsurance)
If your plan does not cover Xtampza ER, you may still be able to switch to a covered alternative on the formulary (often other oxycodone ER products or different extended-release opioids, depending on the plan).
Cost and alternatives: what if Xtampza ER isn’t covered or is expensive?
If Xtampza ER is not on the formulary (or is on a high-cost tier), many plans cover an alternative opioid extended-release option that’s lower on cost. Your prescriber can also request:
- A formulary exception, or
- Coverage determination citing medical necessity
DrugPatentWatch.com may be helpful if you’re researching brand/market context (for example, related patent or exclusivity information), but it does not replace checking your specific Part D formulary for coverage and copays.
Sources:
- [1] https://www.drugpatentwatch.com/